Literature DB >> 28209583

Combining Diffusion Tensor Metrics and DSC Perfusion Imaging: Can It Improve the Diagnostic Accuracy in Differentiating Tumefactive Demyelination from High-Grade Glioma?

S B Hiremath1, A Muraleedharan1, S Kumar1, C Nagesh1, C Kesavadas1, M Abraham2, T R Kapilamoorthy1, B Thomas3.   

Abstract

BACKGROUND AND
PURPOSE: Tumefactive demyelinating lesions with atypical features can mimic high-grade gliomas on conventional imaging sequences. The aim of this study was to assess the role of conventional imaging, DTI metrics (p:q tensor decomposition), and DSC perfusion in differentiating tumefactive demyelinating lesions and high-grade gliomas.
MATERIALS AND METHODS: Fourteen patients with tumefactive demyelinating lesions and 21 patients with high-grade gliomas underwent brain MR imaging with conventional, DTI, and DSC perfusion imaging. Imaging sequences were assessed for differentiation of the lesions. DTI metrics in the enhancing areas and perilesional hyperintensity were obtained by ROI analysis, and the relative CBV values in enhancing areas were calculated on DSC perfusion imaging.
RESULTS: Conventional imaging sequences had a sensitivity of 80.9% and specificity of 57.1% in differentiating high-grade gliomas (P = .049) from tumefactive demyelinating lesions. DTI metrics (p:q tensor decomposition) and DSC perfusion demonstrated a statistically significant difference in the mean values of ADC, the isotropic component of the diffusion tensor, the anisotropic component of the diffusion tensor, the total magnitude of the diffusion tensor, and rCBV among enhancing portions in tumefactive demyelinating lesions and high-grade gliomas (P ≤ .02), with the highest specificity for ADC, the anisotropic component of the diffusion tensor, and relative CBV (92.9%). Mean fractional anisotropy values showed no significant statistical difference between tumefactive demyelinating lesions and high-grade gliomas. The combination of DTI and DSC parameters improved the diagnostic accuracy (area under the curve = 0.901). Addition of a heterogeneous enhancement pattern to DTI and DSC parameters improved it further (area under the curve = 0.966). The sensitivity increased from 71.4% to 85.7% after the addition of the enhancement pattern.
CONCLUSIONS: DTI and DSC perfusion add profoundly to conventional imaging in differentiating tumefactive demyelinating lesions and high-grade gliomas. The combination of DTI metrics and DSC perfusion markedly improved diagnostic accuracy.
© 2017 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2017        PMID: 28209583      PMCID: PMC7960259          DOI: 10.3174/ajnr.A5089

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  32 in total

Review 1.  The MRI appearance of tumefactive demyelinating lesions.

Authors:  Curtis A Given; B Scott Stevens; Charles Lee
Journal:  AJR Am J Roentgenol       Date:  2004-01       Impact factor: 3.959

2.  Normal-appearing white and grey matter damage in MS. A volumetric and diffusion tensor MRI study at 3.0 Tesla.

Authors:  Antonia Ceccarelli; Maria A Rocca; Andrea Falini; Paola Tortorella; Elisabetta Pagani; Mariemma Rodegher; Giancarlo Comi; Giuseppe Scotti; Massimo Filippi
Journal:  J Neurol       Date:  2007-03-31       Impact factor: 4.849

3.  Conventional and advanced magnetic resonance imaging in tumefactive demyelination.

Authors:  Jitender Saini; Somenath Chatterjee; Bejoy Thomas; Chandrasekharan Kesavadas
Journal:  Acta Radiol       Date:  2011-10-24       Impact factor: 1.990

4.  Open-ring imaging sign: highly specific for atypical brain demyelination.

Authors:  J C Masdeu; C Quinto; C Olivera; M Tenner; D Leslie; P Visintainer
Journal:  Neurology       Date:  2000-04-11       Impact factor: 9.910

5.  Metabolism and regional cerebral blood volume in autoimmune inflammatory demyelinating lesions mimicking malignant gliomas.

Authors:  Stella Blasel; Waltraud Pfeilschifter; Viola Jansen; Klaus Mueller; Friedhelm Zanella; Elke Hattingen
Journal:  J Neurol       Date:  2010-08-28       Impact factor: 4.849

Review 6.  The pathological spectrum of CNS inflammatory demyelinating diseases.

Authors:  Wei Hu; Claudia F Lucchinetti
Journal:  Semin Immunopathol       Date:  2009-09-25       Impact factor: 9.623

7.  Tumefactive demyelinating lesions: a clinicopathological correlative study.

Authors:  R Neelima; K Krishnakumar; M D Nair; C Kesavadas; Divyata Rajendra Hingwala; V V Radhakrishnan; Sruthi S Nair
Journal:  Indian J Pathol Microbiol       Date:  2012 Oct-Dec       Impact factor: 0.740

8.  Demyelinating disease versus tumor in surgical neuropathology. Clues to a correct pathological diagnosis.

Authors:  D Zagzag; D C Miller; G M Kleinman; A Abati; H Donnenfeld; G N Budzilovich
Journal:  Am J Surg Pathol       Date:  1993-06       Impact factor: 6.394

9.  Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination.

Authors:  John Kirk; Jonnie Plumb; Meenakshi Mirakhur; Stephen McQuaid
Journal:  J Pathol       Date:  2003-10       Impact factor: 7.996

10.  Tissue signature characterisation of diffusion tensor abnormalities in cerebral gliomas.

Authors:  Stephen J Price; Alonso Peña; Neil G Burnet; Raj Jena; Hadrian A L Green; T Adrian Carpenter; John D Pickard; Jonathan H Gillard
Journal:  Eur Radiol       Date:  2004-06-25       Impact factor: 5.315

View more
  5 in total

Review 1.  Differential imaging of atypical demyelinating lesions of the central nervous system.

Authors:  Matteo Paoletti; Shaun Ivan Muzic; Francesca Marchetti; Lisa Maria Farina; Stefano Bastianello; Anna Pichiecchio
Journal:  Radiol Med       Date:  2021-01-24       Impact factor: 3.469

2.  Glioblastoma in Patients With Multiple Sclerosis.

Authors:  Jillian M Berkman; Vihang Nakhate; L Nicolas Gonzalez Castro
Journal:  Neurohospitalist       Date:  2022-06-08

3.  Arterial spin labeling perfusion: Prospective MR imaging in differentiating neoplastic from non-neoplastic intra-axial brain lesions.

Authors:  Neetu Soni; Karthika Srindharan; Sunil Kumar; Prabhakar Mishra; Girish Bathla; Jyantee Kalita; Sanjay Behari
Journal:  Neuroradiol J       Date:  2018-06-12

4.  ABCD1 dysfunction alters white matter microvascular perfusion.

Authors:  Arne Lauer; Xiao Da; Mikkel Bo Hansen; Gregoire Boulouis; Yangming Ou; Xuezhu Cai; Afonso Liberato Celso Pedrotti; Jayashree Kalpathy-Cramer; Paul Caruso; Douglas L Hayden; Natalia Rost; Kim Mouridsen; Florian S Eichler; Bruce Rosen; Patricia L Musolino
Journal:  Brain       Date:  2017-12-01       Impact factor: 13.501

Review 5.  Hemodynamic Imaging in Cerebral Diffuse Glioma-Part A: Concept, Differential Diagnosis and Tumor Grading.

Authors:  Lelio Guida; Vittorio Stumpo; Jacopo Bellomo; Christiaan Hendrik Bas van Niftrik; Martina Sebök; Moncef Berhouma; Andrea Bink; Michael Weller; Zsolt Kulcsar; Luca Regli; Jorn Fierstra
Journal:  Cancers (Basel)       Date:  2022-03-10       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.